The Effect of Broccoli Glucoraphanin Supplementation on Ameliorating High‐Fat‐Diet‐Induced Obesity through the Gut Microbiome and Metabolome Interface

Scope Obesity and its metabolic comorbidities pose a major global challenge for public health. Glucoraphanin (GRN) is a natural bioactive compound enriched in broccoli that is known to have potential health benefits against various human chronic diseases. Methods and results This study investigats the effects of broccoli GRN supplementation on body weight, metabolic parameters, gut microbiome and metabolome associated with obesity. The study is conducted on an obese‐related C57BL/6J mouse model through the treatment of normal control diet, high‐fat diet (HFD)and GRN‐supplemented HFD (HFD‐GRN) to determine the metabolic protection of GRN. The results shows that GRN treatment alleviates obesity‐related traits leading to improved glucose metabolism in HFD‐fed animals. Mechanically, the study noticed that GRN significantly shifts the gut microbial diversity and composition to an eubiosis status. GRN supplement also significantly alters plasma metabolite profiles. Further integrated analysis reveal a complex interaction between the gut microbes and host metabolism that may contribute to GRN‐induced beneficial effects against HFD. Conclusion These results indicate that beneficial effects of broccoli GRN on reversing HFD‐induced adverse metabolic parameters may be attributed to its impacts on reprogramming microbial community and metabolites. Identification of the mechanistic functions of GRN further warrants it as a dietary candidate for obesity prevention.